| Project/Area Number |
26462045
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Kumamoto University |
|---|
Principal Investigator |
HORINO Kei 熊本大学, 医学部附属病院, 非常勤診療医師 (60452900)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
今井 克憲 熊本大学, 医学部附属病院, 助教 (60555746)
別府 透 熊本大学, 医学部附属病院, 非常勤診療医師 (70301372)
林 洋光 熊本大学, 医学部附属病院, 非常勤診療医師 (80625773)
|
|---|
| Research Collaborator |
SAKAMOTO Keita 熊本大学, 医学部附属病院, 非常勤診療医師
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | P-cadherin / methylation / unmethylation / promoter / invasion / migration / Rho family / Akt/Ark signal / CDH3 / rho family / methylatiom |
|---|
| Outline of Final Research Achievements |
P-cadherin overexpression may serve as a useful biomarker of invasive phenotype and poor prognosis. P-cadherin expression was found to be regulated by its promoter methylation. These results suggest that P-cadherin represents a novel therapeutic target for the treatment of intrahepatic cholangiocarcinoma and pancreatic cancer.
However, how P-cadherin affects tumor behavior is still unclear. There is a discrepancy in its role between different cancer types. We should continue a study of mechanism caused by P-cadherin overexpression.
|
